Frontiers in Medicine (Sep 2021)
Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
- Alberto Alape-Girón,
- Alberto Alape-Girón,
- Andrés Moreira-Soto,
- Mauricio Arguedas,
- Hebleen Brenes,
- Willem Buján,
- Willem Buján,
- Eugenia Corrales-Aguilar,
- Cecilia Díaz,
- Cecilia Díaz,
- Ann Echeverri,
- Marietta Flores-Díaz,
- Aarón Gómez,
- Andrés Hernández,
- María Herrera,
- Guillermo León,
- Román Macaya,
- José Arturo Molina-Mora,
- Javier Mora,
- Aarthi Narayanan,
- Alfredo Sanabria,
- Andrés Sánchez,
- Laura Sánchez,
- Álvaro Segura,
- Eduardo Segura,
- Daniela Solano,
- Claudio Soto,
- Jennifer L. Stynoski,
- Mariángela Vargas,
- Mauren Villalta,
- Jan Felix Drexler,
- José María Gutiérrez
Affiliations
- Alberto Alape-Girón
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Alberto Alape-Girón
- School of Medicine University of Costa Rica, San Pedro, Costa Rica
- Andrés Moreira-Soto
- Institute of Virology, Charité Medical University of Berlin, Berlin, Germany
- Mauricio Arguedas
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Hebleen Brenes
- Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Ministry of Health, Cartago, Costa Rica
- Willem Buján
- School of Medicine University of Costa Rica, San Pedro, Costa Rica
- Willem Buján
- Caja Costarricense del Seguro Social, San Jose, Costa Rica
- Eugenia Corrales-Aguilar
- Research Center for Tropical Diseases, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Cecilia Díaz
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Cecilia Díaz
- School of Medicine University of Costa Rica, San Pedro, Costa Rica
- Ann Echeverri
- Caja Costarricense del Seguro Social, San Jose, Costa Rica
- Marietta Flores-Díaz
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Aarón Gómez
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Andrés Hernández
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- María Herrera
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Guillermo León
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Román Macaya
- Caja Costarricense del Seguro Social, San Jose, Costa Rica
- José Arturo Molina-Mora
- Research Center for Tropical Diseases, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Javier Mora
- Research Center for Tropical Diseases, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Aarthi Narayanan
- National Center for Biodefense and Infectious Diseases, College of Science, George Mason University, Fairfax, VA, United States
- Alfredo Sanabria
- Caja Costarricense del Seguro Social, San Jose, Costa Rica
- Andrés Sánchez
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Laura Sánchez
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Álvaro Segura
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Eduardo Segura
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Daniela Solano
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Claudio Soto
- Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Ministry of Health, Cartago, Costa Rica
- Jennifer L. Stynoski
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Mariángela Vargas
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Mauren Villalta
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- Jan Felix Drexler
- Institute of Virology, Charité Medical University of Berlin, Berlin, Germany
- José María Gutiérrez
- Instituto Clodomiro Picado, School of Microbiology, University of Costa Rica, San Pedro, Costa Rica
- DOI
- https://doi.org/10.3389/fmed.2021.743325
- Journal volume & issue
-
Vol. 8
Abstract
No abstracts available.Keywords
- heterologous antibodies
- passive immunotherapy
- COVID-19
- SARS-CoV-2
- hyperimmune polyclonal antibodies
- convalescent plasma